SAN DIEGO, CA – November 7, 2024 – Antharis Therapeutics is excited to announce that its Founder, Chief Executive Officer, and Chairman, Dr. Raphael Ribeiro-Pinaud, has been invited and interviewed for the latest edition of Partnology’s Biotech Leader Spotlight Series. This series highlights the visionary leadership of pioneering leaders who are driving innovation,creating impactful treatments and transforming the biotech industry.
In his spotlight, Dr. Ribeiro-Pinaud shares insights of his journey from academia, through financial markets, to founding and leading Antharis, which has quickly established itself as an emerging leader in the development of novel, next-generationmonoclonal antibody therapies for oncology. The interview delves into Dr. Ribeiro-Pinaud’s unique multidisciplinary expertise, which combines a strong foundation in science, business management, finance and regulatory affairs—a combination he has been successfully and seamlessly using to advance Antharis’ mission of bringing breakthrough cancer treatments to patients in need, worldwide.
In addition, Dr. Ribeiro-Pinaud discusses in the interview how Antharis’ unique approach of developing therapies that harness the power of immune system against multiple cancer types has paved the way for the development of a robust pipeline of immunotherapies.
The company’s Board of Directors released the following statement in conjunction with Dr. Ribeiro-Pinaud’s invitation to be featured in the Biotech Leader Spotlight Series:
“Our Board of Directors is delighted to see this well-deserved spotlight on our CEO, Dr. Raphael Ribeiro-Pinaud. This interview captures many of the exceptional qualities he demonstrates daily at Antharis: his visionary leadership, multidisciplinary background, relentless determination and focus, as well as an unparalleled capacity to create shareholder’s value. His innovative and creative mind, along with a deep understanding of the industry, have been crucial drivers underlying the momentum and growth that Antharis has achieved to date. We are fortunate to have such a dynamic leader at our helm and are confident that, under his guidance, our company will continue its upward trajectory, advancing our mission to deliver innovative cancer therapies to the patients who need them most.”
To read the full Biotech Leader Spotlight feature on Dr. Ribeiro-Pinaud, visit here.
About Antharis Therapeutics
Antharis Therapeutics is a pioneering biopharmaceutical company focused on advancing immuno-oncology treatments through the development of novel monoclonal antibodies. The company is dedicated to delivering transformative therapies that leverage the body’s immune response to target and treat cancer, with a focus on enhancing patient accessibility and outcomes. For more information, please visit www.antharistherapeutics.com.
